Sanket Kale
About Sanket Kale
Sanket Kale is a Senior Manager of Biometrics at Aimmune Therapeutics, where he has worked since 2018. He has extensive experience in statistical programming, having held various positions at companies such as Parexel, GSK, and Quintiles.
Current Role at Aimmune Therapeutics
Sanket Kale serves as the Senior Manager of Biometrics at Aimmune Therapeutics. He has held this position since 2018, contributing to the company's efforts in biostatistics and data analysis. His role involves overseeing biometrics operations, ensuring the integrity of clinical data, and supporting the development of therapeutic solutions.
Previous Experience at Parexel
Before joining Aimmune Therapeutics, Sanket Kale worked at Parexel as a Senior Manager in Statistical Programming from 2013 to 2018. During his five years in this role, he was based in Raleigh, North Carolina, where he led statistical programming efforts and managed teams to deliver high-quality data analysis for clinical trials.
Education and Expertise
Sanket Kale obtained a Bachelor of Science degree from the University of Mumbai, studying from 1996 to 1999. He furthered his education by earning a Master of Science degree from the University of Texas at Arlington, where he studied from 2001 to 2004. His educational background provides a strong foundation in statistical methodologies and programming.
Career Background in Statistical Programming
Sanket Kale has extensive experience in statistical programming, having worked in various roles across multiple organizations. His career includes positions at GSK as a Statistical SAS Programmer in 2007, at Quintiles as a Clinical Data Programmer in 2008, and at UnitedHealth Group as a Senior Statistical Programmer from 2009 to 2010. He also worked at Maxisit Inc. as a Statistical Programmer from 2005 to 2006.
Tenure at Parexel
In addition to his role as Senior Manager of Statistical Programming from 2013 to 2018, Sanket Kale has been with Parexel since 2010 as a Principal Statistical Programmer. His ongoing tenure at Parexel highlights his expertise in statistical programming and data analysis within the clinical research field.